| review article | Q7318358 |
| scholarly article | Q13442814 |
| P356 | DOI | 10.1007/S10620-007-0079-8 |
| P698 | PubMed publication ID | 17990105 |
| P2093 | author name string | Ahmet Gurakar | |
| Nicolas Jabbour | |||
| Sharad Sharma | |||
| P2860 | cites work | Natural history of portal hypertensive gastropathy in patients with liver cirrhosis. The New Italian Endoscopic Club for the study and treatment of esophageal varices (NIEC) | Q28140457 |
| Mucosal abnormalities of the colon in patients with portal hypertension: an endoscopic study | Q28140625 | ||
| Propranolol in prevention of recurrent bleeding from severe portal hypertensive gastropathy in cirrhosis | Q28244261 | ||
| Portal hypertensive gastropathy in patients with cirrhosis | Q28248654 | ||
| Excessive alcohol consumption favours high risk polyp or colorectal cancer occurrence among patients with adenomas: a case control study | Q28344341 | ||
| Recombinant activated factor VII for coagulopathy in fulminant hepatic failure compared with conventional therapy | Q30310461 | ||
| Endoscopic YAG laser treatment of watermelon stomach (gastric antral vascular ectasia) in patients with systemic sclerosis | Q30959116 | ||
| The clinical and endoscopic spectrum of the watermelon stomach | Q31042754 | ||
| Early administration of vapreotide for variceal bleeding in patients with cirrhosis | Q31797999 | ||
| N-butyl-2-cyanoacrylate pulmonary embolism after endoscopic injection sclerotherapy for gastric variceal bleeding. | Q31930907 | ||
| The watermelon stomach: clinical presentation, diagnosis, and treatment | Q32059053 | ||
| Hepatic vein pressure gradient reduction and prevention of variceal bleeding in cirrhosis: a systematic review | Q33263463 | ||
| Overall experience with NovoSeven | Q33332792 | ||
| Coagulation defects in liver disease. | Q33492583 | ||
| Bucrylate treatment of bleeding gastric varices: 12 years' experience | Q33911695 | ||
| A prospective, randomized trial of butyl cyanoacrylate injection versus band ligation in the management of bleeding gastric varices | Q33945950 | ||
| Effectiveness of the recombinant factor VIIa in patients with the coagulopathy of advanced child's B and C cirrhosis | Q34090313 | ||
| Cirrhosis as an independent risk factor for colonic adenomas | Q34376056 | ||
| Three decades of experience with emergency portacaval shunt for acutely bleeding esophageal varices in 400 unselected patients with cirrhosis of the liver | Q42062143 | ||
| Octreotide infusion or emergency sclerotherapy for variceal haemorrhage | Q42066203 | ||
| Life-threatening hemorrhage of the digestive tract in cirrhotic patients. An assessment of the postoperative mortality after emergency portacaval shunt | Q42096710 | ||
| The effect of immunosuppression on pre-existing cancers | Q42511271 | ||
| UK guidelines on the management of variceal haemorrhage in cirrhotic patients. British Society of Gastroenterology | Q43017858 | ||
| Prevalence, classification and natural history of gastric varices: a long-term follow-up study in 568 portal hypertension patients | Q43468934 | ||
| Colonic mucosal changes in patients with liver cirrhosis | Q43586180 | ||
| Endoscopic ablation with cyanoacrylate glue for isolated gastric variceal bleeding | Q43589315 | ||
| Role of Helicobacter pylori in cirrhotic patients with dyspepsia: a 13C-urea breath test study | Q43747347 | ||
| Recombinant activated factor VII (rFVIIa) acutely normalizes prothrombin time in patients with cirrhosis during bleeding from oesophageal varices | Q43758382 | ||
| Bacterial infections in cirrhosis: epidemiological changes with invasive procedures and norfloxacin prophylaxis | Q43851678 | ||
| Cure of gastric antral vascular ectasia by liver transplantation despite persistent portal hypertension: a clue for pathogenesis | Q44083944 | ||
| Endoscopic sclerotherapy of gastric variceal bleeding with N-butyl-2-cyanoacrylate | Q44111819 | ||
| An open pilot study of the effects of a human fibrin glue for endoscopic treatment of patients with acute bleeding from gastric varices | Q44115191 | ||
| Successful endoscopic obturation of gastric varices with butyl cyanoacrylate | Q44188875 | ||
| The role of propranolol in congestive gastropathy of portal hypertension | Q44215785 | ||
| Use of propranolol to reduce the rebleeding rate during injection sclerotherapy prior to variceal obliteration | Q44217981 | ||
| Incidence and natural history of small esophageal varices in cirrhotic patients | Q44370094 | ||
| Rectosigmoid varices and other mucosal changes in patients with portal hypertension | Q44456891 | ||
| A prospective randomized study to evaluate propranolol in patients undergoing long-term endoscopic sclerotherapy | Q44475552 | ||
| Gastroduodenal ulcer and erosions are related to portal hypertensive gastropathy and recent alcohol intake in cirrhotic patients | Q44488576 | ||
| Propranolol reduces the rebleeding rate during endoscopic sclerotherapy before variceal obliteration | Q44501319 | ||
| Evaluation of propranolol for prevention of recurrent bleeding from esophageal varices between sclerotherapy sessions | Q44569753 | ||
| N-2-butyl-cyanoacrylate for bleeding gastric varices: a United States pilot study and cost analysis | Q44590215 | ||
| Prophylactic endoscopic sclerotherapy of oesophageal varices. A prospective controlled study | Q44600787 | ||
| Norfloxacin vs ceftriaxone in the prophylaxis of infections in patients with advanced cirrhosis and hemorrhage. | Q44613809 | ||
| Clinical Evaluation of Combined Endoscopic Variceal Ligation and Sclerotherapy of Gastric Varices in Liver Cirrhosis | Q44647650 | ||
| Prevalence of upper and lower gastrointestinal tract findings in liver transplant candidates undergoing screening endoscopic evaluation | Q44672676 | ||
| Clinical evaluation of endoscopic injection sclerotherapy using N-butyl-2-cyanoacrylate for gastric variceal bleeding | Q44747228 | ||
| Portal colopathy: prospective study of colonoscopy in patients with portal hypertension | Q44946787 | ||
| Variceal ligation compared with endoscopic sclerotherapy for variceal hemorrhage: prospective randomized trial | Q45104087 | ||
| Prevalence and natural history of gastric antral vascular ectasia in patients undergoing orthotopic liver transplantation | Q45113419 | ||
| Transjugular intrahepatic portosystemic shunt for bleeding angiodysplasia-like lesions in portal-hypertensive colopathy | Q45129610 | ||
| Endoscopic approach to patients with portal hypertension: a complex diagnosis. A retrospective study based on 10 years' experience | Q45209242 | ||
| Splenic infarction complicated by splenic artery occlusion after N-butyl-2-cyanoacrylate injection for gastric varices: case report | Q45281346 | ||
| Frequent endoscopic variceal sclerotherapy increases risk of complications. Prospective randomized controlled study of two treatment schedules. | Q45990733 | ||
| Endoscopic variceal ligation plus propranolol versus endoscopic variceal ligation alone in primary prophylaxis of variceal bleeding | Q46397568 | ||
| Antibiotic prophylaxis of bacterial infections in cirrhotic inpatients: a meta-analysis of randomized controlled trials | Q47991323 | ||
| Stapled hemorrhoidopexy for prolapsed hemorrhoids in patients with liver cirrhosis; a preliminary outcome for 8-case experience. | Q48616742 | ||
| Thrombin--an effective treatment for gastric variceal haemorrhage | Q34382079 | ||
| Longterm follow up of transjugular intrahepatic portosystemic stent shunt (TIPSS) for the treatment of portal hypertension: results in 130 patients | Q34410410 | ||
| Long-term follow-up of gastric variceal sclerotherapy: an eleven-year experience | Q34435778 | ||
| Anorectal varices, haemorrhoids, and portal hypertension | Q34460441 | ||
| Isosorbide mononitrate and propranolol compared with propranolol alone for the prevention of variceal rebleeding | Q34508947 | ||
| Endoscopic variceal ligation plus nadolol and sucralfate compared with ligation alone for the prevention of variceal rebleeding: a prospective, randomized trial | Q34510409 | ||
| Endoscopic treatment versus endoscopic plus pharmacologic treatment for acute variceal bleeding: a meta-analysis. | Q34521372 | ||
| A randomized controlled trial of cyanoacrylate versus alcohol injection in patients with isolated fundic varices | Q34523064 | ||
| Intravariceal versus paravariceal sclerotherapy: a prospective, controlled, randomised trial | Q34528014 | ||
| Comparison of the two time schedules for endoscopic sclerotherapy: a prospective randomised controlled study | Q34529020 | ||
| Endotracheal intubation for airway protection during endoscopy for severe upper GI hemorrhage | Q34530272 | ||
| Antibiotic prophylaxis after endoscopic therapy prevents rebleeding in acute variceal hemorrhage: a randomized trial | Q34546095 | ||
| Emergency sclerotherapy versus medical interventions for bleeding oesophageal varices in cirrhotic patients | Q34546829 | ||
| Variceal ligation plus nadolol compared with ligation for prophylaxis of variceal rebleeding: a multicenter trial | Q34555329 | ||
| A randomized trial of endoscopic treatment of acute gastric variceal hemorrhage: N-butyl-2-cyanoacrylate injection versus band ligation | Q34565930 | ||
| Gastric antral vascular ectasia: the watermelon stomach | Q34708539 | ||
| Risk factors for hemorrhage from gastric fundal varices | Q34737844 | ||
| Emergency banding ligation versus sclerotherapy for the control of active bleeding from esophageal varices | Q34740053 | ||
| Helicobacter pylori infection and peptic ulcer disease in cirrhosis | Q34748056 | ||
| Upper gastrointestinal bleeding in patients with liver cirrhosis. | Q34769780 | ||
| Portal hypertensive colopathy in patients with liver cirrhosis | Q35011011 | ||
| Prevention of initial variceal hemorrhage | Q35253482 | ||
| Management of gastric varices | Q35466113 | ||
| Meta-analysis: endoscopic variceal ligation for primary prophylaxis of oesophageal variceal bleeding | Q36041168 | ||
| Portal hypertensive intestinal vasculopathy: a review of the clinical, endoscopic, and histopathologic features | Q36372137 | ||
| Portal and gastric mucosal hemodynamics in cirrhotic patients with portal-hypertensive gastropathy | Q36729086 | ||
| Endoscopic Ligation Compared with Sclerotherapy for Treatment of Esophageal Variceal Bleeding | Q38574489 | ||
| Endoscopic ligation compared with sclerotherapy for the treatment of bleeding esophageal varices | Q39414961 | ||
| Complications of endoscopic injection sclerotherapy: a review | Q39668247 | ||
| Endoscopic techniques and complications in variceal sclerotherapy | Q39679943 | ||
| The treatment of portal hypertension: A meta-analytic review | Q40439090 | ||
| Recombinant activated factor VII in children with acute bleeding resulting from liver failure and disseminated intravascular coagulation. | Q40620271 | ||
| The natural history of varices | Q40906415 | ||
| Massive bleeding from rectal varices. | Q40912337 | ||
| The prevalence of Helicobacter pylori in peptic ulcer disease. | Q40938590 | ||
| Management of upper gastrointestinal bleeding in the patient with chronic liver disease | Q41109708 | ||
| Impaired oxygenation of gastric mucosa in portal hypertension. The basis for increased susceptibility to injury | Q41349466 | ||
| Diagnosis and treatment of gastrointestinal bleeding secondary to portal hypertension. American College of Gastroenterology Practice Parameters Committee | Q41528946 | ||
| Is smoking still important in the pathogenesis of peptic ulcer disease? | Q41710842 | ||
| Clinical evaluation of endoscopic injection sclerotherapy using n-butyl-2-cyanoacrylate for gastric variceal bleeding | Q42052120 | ||
| UGI bleeding in a nonalcoholic population with portal hypertension | Q72083583 | ||
| Short- and long-term hemodynamic effects of transjugular intrahepatic portosystemic shunts: a Doppler/manometric correlative study | Q72180205 | ||
| The prevalence and spectrum of colonic lesions in patients with cirrhotic and noncirrhotic portal hypertension | Q72210529 | ||
| Portal hypertensive colopathy: endoscopic findings and the relation to portal pressure | Q72328069 | ||
| A prospective randomized trial comparing somatostatin and sclerotherapy in the treatment of acute variceal bleeding | Q72686329 | ||
| Propranolol in the prevention of recurrent upper gastrointestinal bleeding in patients with cirrhosis undergoing endoscopic sclerotherapy. A randomized controlled trial | Q72756397 | ||
| Prevention of rebleeding from oesophageal varices: two-year follow up of a prospective controlled trial of propranolol in addition to sclerotherapy | Q72812620 | ||
| Hypokalemia-induced hepatic coma in cirrhosis. Occurrence despite neomycin therapy | Q72900760 | ||
| Endoscopic Doppler US-guided injection therapy for gastric varices: case report | Q73193671 | ||
| Multiple pulmonary glue emboli following gastric variceal obliteration | Q73484875 | ||
| Management of actively bleeding esophageal varices | Q73595216 | ||
| The use of screening and preventive therapies for gastroesophageal varices in patients referred for evaluation of orthotopic liver transplantation | Q73697865 | ||
| A meta-analysis of endoscopic variceal ligation for primary prophylaxis of esophageal variceal bleeding | Q73704442 | ||
| The potentiating actions of cigarette smoking on ethanol-induced gastric mucosal damage in rats | Q73760599 | ||
| Efficacy of octreotide and sclerotherapy in the treatment of acute variceal bleeding in cirrhotic patients. A prospective, multicentric, and randomized clinical trial | Q73833970 | ||
| Recombinant factor VIIa corrects prothrombin time in cirrhotic patients: a preliminary study | Q73933603 | ||
| Helicobacter pylori infection in congestive gastropathy | Q73941702 | ||
| Gastric antral vascular ectasia with portal hypertension: treatment with TIPSS | Q73943254 | ||
| EUS-guided injection of cyanoacrylate for bleeding gastric varices | Q74097982 | ||
| Portal hypertensive colopathy: histologic appearance of the colonic mucosa | Q74296656 | ||
| Endoscopic use of human thrombin in bleeding gastric varices | Q74402170 | ||
| Colonic disease in cirrhotic patients with portal hypertension: an endoscopic and clinical evaluation | Q74586712 | ||
| Quick correction of hemostasis in two patients with fulminant liver failure undergoing liver transplantation by recombinant activated factor VII | Q74616172 | ||
| Myocardial infarction complicating gastrointestinal hemorrhage | Q74630853 | ||
| Utility of endoscopic evaluations in liver transplant candidates | Q77101948 | ||
| Portal hypertension and variceal bleeding: an AASLD single topic symposium | Q77220747 | ||
| Thrombin is effective in arresting bleeding from gastric variceal hemorrhage | Q77373424 | ||
| In cirrhotic patients variceal bleeding is more frequent in the evening and correlates with severity of liver disease | Q77401765 | ||
| Pulmonary, cerebral and coronary emboli during bucrylate injection of bleeding fundic varices | Q77725953 | ||
| Consequences of living-donor liver transplantation for upper gastrointestinal lesions: high incidence of reflux esophagitis | Q79197379 | ||
| Recombinant factor VIIa for upper gastrointestinal bleeding in patients with cirrhosis: a randomized, double-blind trial | Q80853264 | ||
| The effects of eradication of Helicobacter pylori on the recurrence of duodenal ulcers in patients with cirrhosis | Q81089669 | ||
| Peptic ulcer and its course in cirrhosis: an endoscopic and clinical prospective study. | Q50594537 | ||
| Portal hypertensive gastropathy in chronic hepatitis C patients with bridging fibrosis and compensated cirrhosis: results from the HALT-C trial. | Q50738437 | ||
| Does the addition of methylene blue to the sclerosant improve the accuracy of injections during variceal sclerotherapy? | Q50873296 | ||
| Helicobacter pylori infection among patients with alcoholic and nonalcoholic cirrhosis. | Q50913638 | ||
| Prevalence of gastric ulcer in cirrhotic patients and its relation to portal hypertension. | Q51027717 | ||
| Helicobacter pylori in cirrhotic patients with peptic ulcer disease: a prospective, case controlled study. | Q51041434 | ||
| The course of patients after variceal hemorrhage. | Q52739354 | ||
| Use of fibrin glue (beriplast) in the management of bleeding gastric varices. | Q53855693 | ||
| Cigarettes, alcohol, coffee and peptic ulcer. | Q54428196 | ||
| Prospective randomised study of effect of octreotide on rebleeding from oesophageal varices after endoscopic ligation. | Q54520561 | ||
| Portal hypertensive colopathy | Q57782993 | ||
| Antibiotic Prophylaxis for the Prevention of Bacterial Infections in Cirrhotic Patients with Ascites: A Meta-Analysis | Q58622880 | ||
| Propranolol and sclerotherapy in the prevention of gastrointestinal rebleeding in patients with cirrhosis: a meta-analysis | Q58622892 | ||
| Norfloxacin prevents bacterial infection in cirrhotics with gastrointestinal hemorrhage | Q67555298 | ||
| Prospective randomized comparison of sodium tetradecyl sulfate and polidocanol as variceal sclerosing agents | Q67740785 | ||
| Helicobacter pylori and peptic ulcer diseases: prevalence and association with antral gastritis in 210 patients | Q67821955 | ||
| Peptic ulcer in cirrhotic patients: a short- and long-term study with antisecretory drugs | Q67881202 | ||
| Endoscopic sclerotherapy in the management of gastric variceal haemorrhage | Q67882045 | ||
| Assessment of mucosal defenses in portal hypertensive gastropathy | Q67989076 | ||
| Prediction of the first variceal hemorrhage in patients with cirrhosis of the liver and esophageal varices. A prospective multicenter study | Q68097576 | ||
| Endoscopic sclerotherapy as compared with endoscopic ligation for bleeding esophageal varices | Q68114390 | ||
| Colon cancer in ulcerative colitis | Q68274468 | ||
| Congestive gastropathy and other upper endoscopic findings in 81 consecutive patients undergoing orthotopic liver transplantation | Q68509183 | ||
| Propranolol may prevent recurrence of oesophageal varices after obliteration by endoscopic sclerotherapy | Q68777813 | ||
| Hemorrhoids or rectal varices: defining the cause of massive rectal hemorrhage in patients with portal hypertension | Q68793164 | ||
| Prevalence of endoscopic findings in 510 consecutive individuals with cirrhosis evaluated prospectively | Q68796444 | ||
| Endoscopic injection sclerosis in bleeding gastric varices | Q68803632 | ||
| Control of massive hemorrhage from rectal varices with sclerotherapy | Q68812448 | ||
| Upper gastrointestinal bleeding in patients with esophageal varices. What is the most common source? | Q68826132 | ||
| Nadolol for prevention of variceal rebleeding during the course of endoscopic injection sclerotherapy: a randomized pilot study | Q68835056 | ||
| Prognostic factors in upper G.I. bleeding | Q68877344 | ||
| Noninvasive measurement of the pressure of esophageal varices using an endoscopic gauge: comparison with measurements by variceal puncture in patients undergoing endoscopic sclerotherapy | Q69569634 | ||
| Hemodynamic effects of blood volume restitution following a hemorrhage in rats with portal hypertension due to cirrhosis of the liver: influence of the extent of portal-systemic shunting | Q69599509 | ||
| Human thrombin plus 5 per cent ethanolamine oleate injected to sclerose oesophageal varices: a prospective randomized trial | Q69693409 | ||
| Portal hypertension with varices in unusual sites | Q70029136 | ||
| Prophylactic sclerotherapy for esophageal varices in men with alcoholic liver disease. A randomized, single-blind, multicenter clinical trial | Q70165121 | ||
| Prophylactic endoscopic sclerosing treatment of the esophageal wall in varices -- a prospective controlled randomized trial | Q70213528 | ||
| Variceal hemorrhage: a critical evaluation of survival analysis | Q70219000 | ||
| Prophylactic sclerotherapy of high-risk esophageal varices: results of a multicentric prospective controlled trial | Q70226679 | ||
| Fatal hemorrhage from rectal varices. Report of two cases | Q70228292 | ||
| Hypophosphatemia in the alcoholic | Q70650452 | ||
| Risk and natural history of colonic neoplasia in patients with primary sclerosing cholangitis and ulcerative colitis | Q70912535 | ||
| Acute upper gastrointestinal bleeding in patients with portal hypertension: a correlation of endoscopic findings with etiology | Q70984596 | ||
| Upper gastrointestinal bleeding in patients with portal hypertension: a reappraisal | Q70986952 | ||
| Gastric mucus generation in cirrhotic patients with portal hypertension. Effects of tetraprenylacetone | Q71506730 | ||
| Prevalence and factors influencing hemorrhoids, anorectal varices, and colopathy in patients with portal hypertension | Q71546355 | ||
| Portal hypertensive gastropathy | Q71620909 | ||
| Systemic antibiotic prophylaxis after gastrointestinal hemorrhage in cirrhotic patients with a high risk of infection | Q71650807 | ||
| Ethanolamine Oleate Versus Butyl Cyanoacrylate for Bleeding Gastric Varices: a Nonrandomized Study | Q71813316 | ||
| P433 | issue | 7 | |
| P304 | page(s) | 1757-1773 | |
| P577 | publication date | 2007-11-09 | |
| P1433 | published in | Digestive Diseases and Sciences | Q15716711 |
| P1476 | title | Avoiding pitfalls: what an endoscopist should know in liver transplantation--part 1. | |
| P478 | volume | 53 |
| Q38476069 | Gastrointestinal endoscopy in the cirrhotic patient | cites work | P2860 |
Search more.